

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 6.10216246 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 4.85344712 |
| 3 | platelet dense granule organization (GO:0060155) | 4.20368625 |
| 4 | DNA deamination (GO:0045006) | 3.79031815 |
| 5 | thrombin receptor signaling pathway (GO:0070493) | 3.69973919 |
| 6 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.61996365 |
| 7 | cellular biogenic amine catabolic process (GO:0042402) | 3.54069663 |
| 8 | amine catabolic process (GO:0009310) | 3.54069663 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 3.53645503 |
| 10 | purine nucleotide salvage (GO:0032261) | 3.50606287 |
| 11 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.48116627 |
| 12 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.48116627 |
| 13 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.42333159 |
| 14 | neutrophil activation (GO:0042119) | 3.40863622 |
| 15 | granulocyte activation (GO:0036230) | 3.35907126 |
| 16 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.29023251 |
| 17 | adenosine metabolic process (GO:0046085) | 3.26058638 |
| 18 | behavioral response to nicotine (GO:0035095) | 3.18886201 |
| 19 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.17221594 |
| 20 | sequestering of actin monomers (GO:0042989) | 3.14250143 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 3.11478518 |
| 22 | positive regulation of defense response to virus by host (GO:0002230) | 3.10763177 |
| 23 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.09617316 |
| 24 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.06005764 |
| 25 | adaptation of signaling pathway (GO:0023058) | 3.02854180 |
| 26 | regulation of memory T cell differentiation (GO:0043380) | 3.01270155 |
| 27 | polyamine biosynthetic process (GO:0006596) | 2.99003125 |
| 28 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.97109350 |
| 29 | negative regulation of heart rate (GO:0010459) | 2.95659250 |
| 30 | regulation of vitamin metabolic process (GO:0030656) | 2.95654858 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.90397002 |
| 32 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89817420 |
| 33 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.88910409 |
| 34 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.88910409 |
| 35 | NADH dehydrogenase complex assembly (GO:0010257) | 2.88910409 |
| 36 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.86479361 |
| 37 | protein complex biogenesis (GO:0070271) | 2.85886179 |
| 38 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.81736369 |
| 39 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.80673592 |
| 40 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.75797590 |
| 41 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75434788 |
| 42 | phagosome maturation (GO:0090382) | 2.75093670 |
| 43 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.74678547 |
| 44 | cysteine metabolic process (GO:0006534) | 2.74336933 |
| 45 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74217061 |
| 46 | regulation of endothelial cell differentiation (GO:0045601) | 2.71699756 |
| 47 | polyamine metabolic process (GO:0006595) | 2.69362304 |
| 48 | negative regulation of interleukin-1 production (GO:0032692) | 2.68893517 |
| 49 | lipoxygenase pathway (GO:0019372) | 2.68148717 |
| 50 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.67277816 |
| 51 | cellular response to zinc ion (GO:0071294) | 2.66189973 |
| 52 | negative regulation of response to food (GO:0032096) | 2.65121904 |
| 53 | negative regulation of appetite (GO:0032099) | 2.65121904 |
| 54 | purine-containing compound salvage (GO:0043101) | 2.64840078 |
| 55 | amine biosynthetic process (GO:0009309) | 2.62763021 |
| 56 | positive regulation of mast cell degranulation (GO:0043306) | 2.59334522 |
| 57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.59334522 |
| 58 | kynurenine metabolic process (GO:0070189) | 2.58328321 |
| 59 | response to xenobiotic stimulus (GO:0009410) | 2.57165791 |
| 60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.56445012 |
| 61 | regulation of platelet activation (GO:0010543) | 2.53969947 |
| 62 | response to pheromone (GO:0019236) | 2.52071874 |
| 63 | tryptophan catabolic process (GO:0006569) | 2.49884322 |
| 64 | indole-containing compound catabolic process (GO:0042436) | 2.49884322 |
| 65 | indolalkylamine catabolic process (GO:0046218) | 2.49884322 |
| 66 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.49691668 |
| 67 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.49403538 |
| 68 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.48971601 |
| 69 | cytidine deamination (GO:0009972) | 2.47611654 |
| 70 | cytidine metabolic process (GO:0046087) | 2.47611654 |
| 71 | cytidine catabolic process (GO:0006216) | 2.47611654 |
| 72 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.45637836 |
| 73 | negative regulation of lipid storage (GO:0010888) | 2.42503327 |
| 74 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.40930183 |
| 75 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.40060289 |
| 76 | actin nucleation (GO:0045010) | 2.39700772 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 2.38757422 |
| 78 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.37613609 |
| 79 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.37613609 |
| 80 | negative regulation of mast cell activation (GO:0033004) | 2.35718443 |
| 81 | leukocyte degranulation (GO:0043299) | 2.35567156 |
| 82 | positive regulation of T cell apoptotic process (GO:0070234) | 2.34135309 |
| 83 | cellular response to nicotine (GO:0071316) | 2.33403253 |
| 84 | regulation of T-helper 1 type immune response (GO:0002825) | 2.33348886 |
| 85 | blood coagulation, intrinsic pathway (GO:0007597) | 2.30642085 |
| 86 | amino acid salvage (GO:0043102) | 2.30095343 |
| 87 | L-methionine salvage (GO:0071267) | 2.30095343 |
| 88 | L-methionine biosynthetic process (GO:0071265) | 2.30095343 |
| 89 | glycerophospholipid catabolic process (GO:0046475) | 2.28567558 |
| 90 | negative regulation of membrane potential (GO:0045837) | 2.28350765 |
| 91 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.27866799 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 2.26178947 |
| 93 | detection of light stimulus involved in visual perception (GO:0050908) | 2.25566336 |
| 94 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.25566336 |
| 95 | regulation of plasminogen activation (GO:0010755) | 2.25346552 |
| 96 | interferon-gamma secretion (GO:0072643) | 2.25156653 |
| 97 | neuromuscular process controlling posture (GO:0050884) | 2.25035087 |
| 98 | negative regulation of interleukin-12 production (GO:0032695) | 2.24934757 |
| 99 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.24084473 |
| 100 | negative regulation of interleukin-17 production (GO:0032700) | 2.23908889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.84104108 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.27269445 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27282480 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.07305120 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.90688851 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46219625 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.45304707 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.25615509 |
| 9 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.19954312 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10633850 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02301802 |
| 12 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95410283 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.91194698 |
| 14 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82736114 |
| 15 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75573059 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.73242761 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72878517 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.70715668 |
| 19 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67957044 |
| 20 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.64812003 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.64348349 |
| 22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59571631 |
| 23 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.56673459 |
| 24 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52863191 |
| 25 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.50911683 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46368787 |
| 27 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.44566291 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.43548088 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42853866 |
| 30 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.41697910 |
| 31 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40260072 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.37041382 |
| 33 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.36206154 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35654685 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31501478 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.30959671 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28018092 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.27093869 |
| 39 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.25319030 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25243402 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19212072 |
| 42 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.18613887 |
| 43 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18500163 |
| 44 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18500163 |
| 45 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.18339958 |
| 46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.16216756 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.15781172 |
| 48 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14802473 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12882556 |
| 50 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12120101 |
| 51 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12120101 |
| 52 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.10833283 |
| 53 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09944012 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09751577 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07093288 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06630650 |
| 57 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.06519625 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04807088 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04222404 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04126030 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.03372461 |
| 62 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03007790 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02436881 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02371856 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02234086 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01785171 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00763170 |
| 68 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00733628 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99259645 |
| 70 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.97043148 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96773023 |
| 72 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95899526 |
| 73 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95491467 |
| 74 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95063718 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93589487 |
| 76 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93073456 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.92535048 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92498266 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91243002 |
| 80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89202162 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89077990 |
| 82 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.88979124 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88616745 |
| 84 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.86741856 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85426266 |
| 86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84704553 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 0.84622668 |
| 88 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84207427 |
| 89 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.83525326 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 0.83010204 |
| 91 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.82623905 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.82403826 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82391483 |
| 94 | ERA_21632823_ChIP-Seq_H3396_Human | 0.80661115 |
| 95 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.80657444 |
| 96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.80552943 |
| 97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80416005 |
| 98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80293191 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.80076124 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79778521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.23559637 |
| 2 | MP0005464_abnormal_platelet_physiology | 4.16314407 |
| 3 | MP0003303_peritoneal_inflammation | 3.01058932 |
| 4 | MP0008004_abnormal_stomach_pH | 2.59419108 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.50039608 |
| 6 | MP0000372_irregular_coat_pigmentation | 2.45159504 |
| 7 | MP0009764_decreased_sensitivity_to | 2.29906998 |
| 8 | MP0003186_abnormal_redox_activity | 2.21906146 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 2.19577750 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.17572020 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.06773362 |
| 12 | MP0005671_abnormal_response_to | 2.04618604 |
| 13 | MP0005360_urolithiasis | 1.89693711 |
| 14 | MP0009785_altered_susceptibility_to | 1.89190280 |
| 15 | MP0000343_altered_response_to | 1.89007378 |
| 16 | MP0003011_delayed_dark_adaptation | 1.87145142 |
| 17 | MP0002736_abnormal_nociception_after | 1.85145597 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.83430838 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 1.75352821 |
| 20 | MP0000015_abnormal_ear_pigmentation | 1.73644313 |
| 21 | MP0002095_abnormal_skin_pigmentation | 1.69080893 |
| 22 | MP0004142_abnormal_muscle_tone | 1.67910863 |
| 23 | MP0005410_abnormal_fertilization | 1.67873802 |
| 24 | MP0003646_muscle_fatigue | 1.65898355 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.61971651 |
| 26 | MP0008872_abnormal_physiological_respon | 1.59718604 |
| 27 | MP0000230_abnormal_systemic_arterial | 1.56876384 |
| 28 | MP0003879_abnormal_hair_cell | 1.56775831 |
| 29 | MP0003436_decreased_susceptibility_to | 1.56321025 |
| 30 | MP0003136_yellow_coat_color | 1.56162635 |
| 31 | MP0003195_calcinosis | 1.54472023 |
| 32 | MP0004147_increased_porphyrin_level | 1.53906524 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.47628462 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.45112370 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.39800601 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.36558747 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.35468612 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.32474467 |
| 39 | MP0002723_abnormal_immune_serum | 1.30676980 |
| 40 | MP0009765_abnormal_xenobiotic_induced | 1.30017319 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.29879109 |
| 42 | MP0001663_abnormal_digestive_system | 1.29537416 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.29204507 |
| 44 | MP0002419_abnormal_innate_immunity | 1.29007544 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.26204493 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.25895337 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.25895337 |
| 48 | MP0002733_abnormal_thermal_nociception | 1.22951112 |
| 49 | MP0002938_white_spotting | 1.22580703 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.22528348 |
| 51 | MP0005025_abnormal_response_to | 1.21388429 |
| 52 | MP0001800_abnormal_humoral_immune | 1.18511453 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.18404917 |
| 54 | MP0001970_abnormal_pain_threshold | 1.17992441 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.17874387 |
| 56 | MP0001919_abnormal_reproductive_system | 1.16455313 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.15293493 |
| 58 | MP0009379_abnormal_foot_pigmentation | 1.14360445 |
| 59 | MP0004885_abnormal_endolymph | 1.13338620 |
| 60 | MP0003638_abnormal_response/metabolism_ | 1.11965541 |
| 61 | MP0001905_abnormal_dopamine_level | 1.11307607 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.09043083 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.08113873 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.06135729 |
| 65 | MP0009763_increased_sensitivity_to | 1.04606724 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.04137353 |
| 67 | MP0005387_immune_system_phenotype | 1.03647882 |
| 68 | MP0001790_abnormal_immune_system | 1.03647882 |
| 69 | MP0006082_CNS_inflammation | 1.03287038 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.00322301 |
| 71 | MP0010329_abnormal_lipoprotein_level | 0.98716202 |
| 72 | MP0000371_diluted_coat_color | 0.98455601 |
| 73 | MP0010155_abnormal_intestine_physiology | 0.97891693 |
| 74 | MP0005408_hypopigmentation | 0.97138121 |
| 75 | MP0008469_abnormal_protein_level | 0.96821086 |
| 76 | MP0001542_abnormal_bone_strength | 0.94792809 |
| 77 | MP0008995_early_reproductive_senescence | 0.93266469 |
| 78 | MP0001819_abnormal_immune_cell | 0.92916928 |
| 79 | MP0002420_abnormal_adaptive_immunity | 0.92147131 |
| 80 | MP0003075_altered_response_to | 0.89590243 |
| 81 | MP0000685_abnormal_immune_system | 0.87379754 |
| 82 | MP0002272_abnormal_nervous_system | 0.87205888 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.86850042 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.86397873 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.86129630 |
| 86 | MP0005332_abnormal_amino_acid | 0.84644079 |
| 87 | MP0004130_abnormal_muscle_cell | 0.84012765 |
| 88 | MP0005171_absent_coat_pigmentation | 0.83054491 |
| 89 | MP0005253_abnormal_eye_physiology | 0.82391500 |
| 90 | MP0002102_abnormal_ear_morphology | 0.81901608 |
| 91 | MP0005389_reproductive_system_phenotype | 0.80359067 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.80299062 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.78311399 |
| 94 | MP0004510_myositis | 0.77228132 |
| 95 | MP0009046_muscle_twitch | 0.76782250 |
| 96 | MP0001756_abnormal_urination | 0.73634351 |
| 97 | MP0006072_abnormal_retinal_apoptosis | 0.72196024 |
| 98 | MP0001324_abnormal_eye_pigmentation | 0.71384841 |
| 99 | MP0002295_abnormal_pulmonary_circulatio | 0.71069777 |
| 100 | MP0004947_skin_inflammation | 0.70856792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 4.70644685 |
| 2 | Prolonged bleeding time (HP:0003010) | 4.36777879 |
| 3 | Purpura (HP:0000979) | 4.34834240 |
| 4 | Congenital sensorineural hearing impairment (HP:0008527) | 3.90960943 |
| 5 | Decreased central vision (HP:0007663) | 3.84790464 |
| 6 | Menorrhagia (HP:0000132) | 3.61600372 |
| 7 | Generalized aminoaciduria (HP:0002909) | 3.56708044 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.47867661 |
| 9 | Stomatitis (HP:0010280) | 3.46334764 |
| 10 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.44004070 |
| 11 | Abnormality of alanine metabolism (HP:0010916) | 3.42294921 |
| 12 | Hyperalaninemia (HP:0003348) | 3.42294921 |
| 13 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.42294921 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.41545084 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.33493511 |
| 16 | Agitation (HP:0000713) | 3.29798399 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.20206963 |
| 18 | Increased mean platelet volume (HP:0011877) | 3.18252832 |
| 19 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.15647310 |
| 20 | Polyphagia (HP:0002591) | 3.13034070 |
| 21 | Epistaxis (HP:0000421) | 3.10066668 |
| 22 | Acute encephalopathy (HP:0006846) | 3.04459985 |
| 23 | Abnormal platelet volume (HP:0011876) | 2.93872598 |
| 24 | Nausea (HP:0002018) | 2.87250457 |
| 25 | Progressive macrocephaly (HP:0004481) | 2.84981656 |
| 26 | Pendular nystagmus (HP:0012043) | 2.80696207 |
| 27 | Gingival bleeding (HP:0000225) | 2.79274734 |
| 28 | Mitochondrial inheritance (HP:0001427) | 2.77757717 |
| 29 | Abolished electroretinogram (ERG) (HP:0000550) | 2.69732279 |
| 30 | Episodic fever (HP:0001954) | 2.62344284 |
| 31 | Constricted visual fields (HP:0001133) | 2.59336365 |
| 32 | Hepatic necrosis (HP:0002605) | 2.57935800 |
| 33 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54142642 |
| 34 | Abnormality of the costochondral junction (HP:0000919) | 2.53760093 |
| 35 | Hypomagnesemia (HP:0002917) | 2.52036380 |
| 36 | Hepatocellular necrosis (HP:0001404) | 2.47621086 |
| 37 | Attenuation of retinal blood vessels (HP:0007843) | 2.42751313 |
| 38 | Keratoconus (HP:0000563) | 2.41755282 |
| 39 | Increased corneal curvature (HP:0100692) | 2.41755282 |
| 40 | Abnormality of magnesium homeostasis (HP:0004921) | 2.39169609 |
| 41 | Increased CSF lactate (HP:0002490) | 2.34294883 |
| 42 | 3-Methylglutaconic aciduria (HP:0003535) | 2.31439122 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.30234920 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29634653 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29634653 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29634653 |
| 47 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21138549 |
| 48 | Type 2 muscle fiber atrophy (HP:0003554) | 2.17991277 |
| 49 | Paralysis (HP:0003470) | 2.15984994 |
| 50 | Albinism (HP:0001022) | 2.13644151 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.11502626 |
| 52 | Oligomenorrhea (HP:0000876) | 2.11143484 |
| 53 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.10622686 |
| 54 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.10622686 |
| 55 | Disinhibition (HP:0000734) | 2.08721819 |
| 56 | White forelock (HP:0002211) | 2.07986629 |
| 57 | Poikilocytosis (HP:0004447) | 2.07407840 |
| 58 | Optic disc pallor (HP:0000543) | 2.06098428 |
| 59 | Molar tooth sign on MRI (HP:0002419) | 1.99089428 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 1.99089428 |
| 61 | Disproportionate short-trunk short stature (HP:0003521) | 1.98562894 |
| 62 | Muscle fiber atrophy (HP:0100295) | 1.96048683 |
| 63 | Abnormal pupillary function (HP:0007686) | 1.95809698 |
| 64 | Increased serum ferritin (HP:0003281) | 1.93796134 |
| 65 | Abnormality of iron homeostasis (HP:0011031) | 1.93451688 |
| 66 | Cerebral edema (HP:0002181) | 1.93044930 |
| 67 | Abnormality of lateral ventricle (HP:0030047) | 1.92803292 |
| 68 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.91800951 |
| 69 | Congenital stationary night blindness (HP:0007642) | 1.91063936 |
| 70 | Patchy hypopigmentation of hair (HP:0011365) | 1.90001449 |
| 71 | Dyschromatopsia (HP:0007641) | 1.88037413 |
| 72 | Progressive neurologic deterioration (HP:0002344) | 1.87828987 |
| 73 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.87374461 |
| 74 | Hypoplasia of the fovea (HP:0007750) | 1.87374461 |
| 75 | Myositis (HP:0100614) | 1.87235513 |
| 76 | Metaphyseal irregularity (HP:0003025) | 1.86750968 |
| 77 | Hepatosplenomegaly (HP:0001433) | 1.86143875 |
| 78 | Conjunctival telangiectasia (HP:0000524) | 1.85812177 |
| 79 | Increased serum lactate (HP:0002151) | 1.85419478 |
| 80 | Renal Fanconi syndrome (HP:0001994) | 1.84541903 |
| 81 | Pachygyria (HP:0001302) | 1.83621415 |
| 82 | Abnormality of the prostate (HP:0008775) | 1.83020845 |
| 83 | Abnormality of the corticospinal tract (HP:0002492) | 1.82423506 |
| 84 | IgG deficiency (HP:0004315) | 1.81594812 |
| 85 | Psychosis (HP:0000709) | 1.81077830 |
| 86 | Lactic acidosis (HP:0003128) | 1.80740233 |
| 87 | Acanthocytosis (HP:0001927) | 1.79646285 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79617186 |
| 89 | Abnormality of macrophages (HP:0004311) | 1.78330586 |
| 90 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.78257856 |
| 91 | Anorexia (HP:0002039) | 1.76259373 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75379013 |
| 93 | Abnormal hemoglobin (HP:0011902) | 1.74061863 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 1.72955873 |
| 95 | Optic neuritis (HP:0100653) | 1.72955873 |
| 96 | Visual hallucinations (HP:0002367) | 1.70704660 |
| 97 | Increased IgM level (HP:0003496) | 1.69773262 |
| 98 | Lissencephaly (HP:0001339) | 1.68911049 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.68622783 |
| 100 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.66696024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 2.82900222 |
| 2 | PIM2 | 2.43533842 |
| 3 | TAOK3 | 2.35119350 |
| 4 | EPHB2 | 2.25459815 |
| 5 | TLK1 | 2.12945749 |
| 6 | MAP4K2 | 2.12564348 |
| 7 | MST4 | 2.12217955 |
| 8 | EIF2AK1 | 2.06572827 |
| 9 | MAP3K11 | 2.02490409 |
| 10 | PINK1 | 2.01704867 |
| 11 | ACVR1B | 1.84055164 |
| 12 | RIPK4 | 1.78215973 |
| 13 | TIE1 | 1.78106401 |
| 14 | BMPR2 | 1.72427199 |
| 15 | BCKDK | 1.71558996 |
| 16 | IKBKB | 1.63406200 |
| 17 | ZAK | 1.63059279 |
| 18 | GRK1 | 1.62971698 |
| 19 | TEC | 1.60333815 |
| 20 | DYRK2 | 1.57112148 |
| 21 | NME2 | 1.55933671 |
| 22 | MATK | 1.55455138 |
| 23 | MYLK | 1.52147768 |
| 24 | MINK1 | 1.44672665 |
| 25 | SYK | 1.44284600 |
| 26 | FGR | 1.43935514 |
| 27 | MARK3 | 1.38255058 |
| 28 | MAP3K3 | 1.32918511 |
| 29 | LIMK1 | 1.31874289 |
| 30 | WNK4 | 1.30297220 |
| 31 | PNCK | 1.29685845 |
| 32 | CSF1R | 1.28789011 |
| 33 | STK16 | 1.28394501 |
| 34 | GRK5 | 1.25969998 |
| 35 | JAK3 | 1.25278071 |
| 36 | IRAK3 | 1.23966984 |
| 37 | MAP4K1 | 1.21415578 |
| 38 | GRK7 | 1.19557091 |
| 39 | ARAF | 1.18683484 |
| 40 | GRK6 | 1.18194409 |
| 41 | TXK | 1.15806298 |
| 42 | ABL2 | 1.11066965 |
| 43 | PLK2 | 1.08783501 |
| 44 | NUAK1 | 1.08284114 |
| 45 | BMX | 1.06239882 |
| 46 | TRIM28 | 1.05625315 |
| 47 | BTK | 1.03029298 |
| 48 | ADRBK1 | 1.01956047 |
| 49 | PTK2B | 0.98563834 |
| 50 | MAP3K12 | 0.95546520 |
| 51 | KIT | 0.94004349 |
| 52 | SGK223 | 0.93403417 |
| 53 | SGK494 | 0.93403417 |
| 54 | DAPK3 | 0.92086653 |
| 55 | STK39 | 0.89985568 |
| 56 | TBK1 | 0.87691842 |
| 57 | LYN | 0.85944916 |
| 58 | DDR2 | 0.84935151 |
| 59 | BMPR1B | 0.84410346 |
| 60 | SGK2 | 0.82280175 |
| 61 | IKBKE | 0.80473028 |
| 62 | MAPKAPK3 | 0.79461458 |
| 63 | PRKCG | 0.77826860 |
| 64 | MAP3K5 | 0.77785858 |
| 65 | ZAP70 | 0.77170903 |
| 66 | CSK | 0.73944102 |
| 67 | TAOK2 | 0.72642818 |
| 68 | MAP2K3 | 0.69904121 |
| 69 | OXSR1 | 0.69300249 |
| 70 | PHKG1 | 0.68895344 |
| 71 | PHKG2 | 0.68895344 |
| 72 | ERBB3 | 0.68624682 |
| 73 | EPHA3 | 0.66895983 |
| 74 | FES | 0.66797299 |
| 75 | PIM1 | 0.65441341 |
| 76 | DAPK2 | 0.64249317 |
| 77 | MAP2K1 | 0.64212714 |
| 78 | PIK3CG | 0.63959349 |
| 79 | BLK | 0.60682069 |
| 80 | PAK1 | 0.60199937 |
| 81 | DYRK3 | 0.59698912 |
| 82 | MAPK13 | 0.59403978 |
| 83 | PRKCD | 0.57616284 |
| 84 | MAP2K7 | 0.55448405 |
| 85 | FRK | 0.55097595 |
| 86 | AURKA | 0.54594711 |
| 87 | CDK19 | 0.53424814 |
| 88 | KDR | 0.52731500 |
| 89 | PRKACA | 0.51376892 |
| 90 | CSNK1G3 | 0.50566276 |
| 91 | CAMK1 | 0.50288288 |
| 92 | CSNK1G1 | 0.50132413 |
| 93 | RPS6KA2 | 0.49475527 |
| 94 | PRKCQ | 0.48955545 |
| 95 | RPS6KA6 | 0.48757264 |
| 96 | PRKCA | 0.47570729 |
| 97 | WNK3 | 0.46918094 |
| 98 | FER | 0.46901207 |
| 99 | ABL1 | 0.45481897 |
| 100 | SGK3 | 0.44992949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.26951744 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.01913347 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.82108051 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.78746978 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.78261440 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.76241140 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.72329352 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55156110 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.31215133 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.21348841 |
| 11 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.18730642 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.17429589 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05676338 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.01549702 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97095523 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85300767 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.62009334 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.58995054 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56932622 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55802191 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54040173 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.44099229 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31709131 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.26887561 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25987697 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25632608 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.24678677 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24215574 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.21414722 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.20128151 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17973489 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11157148 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.09942149 |
| 34 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06729800 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06297254 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03321530 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02728130 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.01888057 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01413259 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00284971 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97495825 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97406215 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95805345 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95295059 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.94919394 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94296675 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93118632 |
| 48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.92562404 |
| 49 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92073863 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.90755865 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90534842 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90198477 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89972111 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89938369 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87833937 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86834651 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83061014 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81567916 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81005066 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78969646 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.78282658 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.77913461 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76491572 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.76105735 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75336158 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.75227863 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73944786 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73385961 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72833672 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.70315489 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68747692 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65694485 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.65325074 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62944797 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61843591 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59632958 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58925386 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.58123907 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57692414 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55677080 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55440065 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54959444 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54700443 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54522484 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53598113 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51836133 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.50997504 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50944887 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49581062 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48042178 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.47803959 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47150001 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46191433 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.44754837 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42359978 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41197749 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40532649 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38810036 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38159121 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36661077 |

